首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
DRUCKER, BILDAUFZEICHNUNGSVERFAHREN UND AUFZEICHNUNGSMATERIAL
摘要
申请公布号
DE69821596(T2)
申请公布日期
2004.12.16
申请号
DE19986021596T
申请日期
1998.04.01
申请人
SEIKO EPSON CORP., TOKIO/TOKYO
发明人
SHIMADA, KAZUMICHI;KAKUTANI, TOSHIAKI;YONEKUBO, SHUJI;KATAKURA, TAKAHIRO
分类号
G06K15/10;H04N1/405;(IPC1-7):B41J2/205;B41J2/21
主分类号
G06K15/10
代理机构
代理人
主权项
地址
您可能感兴趣的专利
CONTROL DEVICE FOR INTERNAL COMBUSTION ENGINE
IMPROVEMENT OF CONCENTRATE QUALITY IN ENRICHMENT OF UG-2 PLATINUM ORE
INPUT DEVICE, INPUT METHOD AND PROGRAM
COMPOSITIONS OF DIBROMOMALONAMIDE AND THEIR USE AS BIOCIDES
METHODS, PROBE SETS, AND KITS FOR DETECTION OF DELETION OF TUMOR SUPPRESSOR GENES BY FLUORESCENCE IN SITU HYBRIDIZATION
VEHICLE SURROUNDINGS MONITORING DEVICE
ANTI-GLARE FILM, MANUFACTURING METHOD FOR SAME, POLARIZING PLATE AND IMAGE DISPLAY DEVICE
MEDICAL NEEDLE SAFETY DEVICE
COMPOSITIONS OF ROSE HIPS ENRICHED WITH SEEDS OF ROSE HIPS AND THEIR USE AS ANTI-INFLAMMATORY NATURAL MEDICINE FOR ALLEVIATING/REDUCING SYMPTOMS ASSOCIATED WITH INFLAMMATION AND JOINT DISEASES SUCH AS ARTHRITIS, RHEUMATOID ARTHRITIS AND/OR OSTEO-ARTH
IRON-TYPE GOLF CLUB HEAD OR OTHER BALL STRIKING DEVICE
CONDUCTIVE PARTICLE, METHOD FOR MANUFACTURING CONDUCTIVE PARTICLE, ANISOTROPIC CONDUCTIVE MATERIAL, AND CONNECTION STRUCTURE
CURABLE COMPOSITION, DICING-DIE BONDING TAPE, CONNECTING STRUCTURE AND METHOD FOR PRODUCING SEMICONDUCTOR TAPE WITH COHESIVE/ADHESIVE LAYER
SAFETY DEVICE MOUNTING ARRANGEMENT
COMPOSITION AND METHOD FOR FORMING AN ALUMINUM FILM
Vorrichtung und Verfahren zur Plasmabehandlung von lebendem Gewebe
ANTI-SHAKE CIRCUIT FOR AN IMAGING DEVICE
Method for defoaming and/or prevention of foam of medium in container of painting system that is utilized for painting motor vehicle, involves applying anti-foam or foam-breaking substance by spraying body that comprises nozzles
Streckwerk mit Führungstisch für ein Führungsriemchen
METHOD, BASE STATION AND RELAY NODE FOR UPLINK TRANSMISSION
COMBINATION OF A GPR119 AGONIST AND THE DPP-IV INHIBITOR LINAGLIPTIN FOR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS
